1006.65
-1.10%
KRChoksey
For Q3FY24, TATVA revenue was INR 842 Mn which declined by 30.2% YoY and 12.9% QoQ. This significant decline was due to continued subdued demand for the specialty chemical industry and financial year-end for global end customers.
Tatva Chintan Pharma Chem Ltd. is trading at high day volume of 130.1K.
More from Tatva Chintan Pharma Chem Ltd.
Recommended